Cite
HARVARD Citation
Macfarlane, S. et al. (n.d.). P4‐356: Safety and Efficacy 31 Week Data of Anavex 2‐73 in a Phase 2A Study in Mild‐Moderate Alzheimer'S Disease Patients. Alzheimer's & dementia. p. P1174. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Macfarlane, S. et al. (n.d.). P4‐356: Safety and Efficacy 31 Week Data of Anavex 2‐73 in a Phase 2A Study in Mild‐Moderate Alzheimer'S Disease Patients. Alzheimer's & dementia. p. P1174. [Online].